רלבר אליפטה 22 / 92 מק"ג - Relvar ellipta 92/22 mcg: הבדלים בין גרסאות

AsthmaRelvar Ellipta is indicated for the regular treatment of asthma in adults and adolescents aged 12 years and older where use of a combination medicinal product (long-acting beta-2-agonist and inhaled corticosteroid) is appropriate:• patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting beta-2-agonists.• patients already adequately controlled on both inhaled corticosteroid and long-acting beta-2-agonist.COPD (Chronic Obstructive Pulmonary Disease)Relvar Ellipta is indicated for the symptomatic treatment of adults with COPD with a FEV1<70% predicted normal (post-bronchodilator) with an exacerbation history despite regular bronchodilator therapy.